Tokio Marine Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.3M Buy
70,824
+3,151
+5% +$184K 0.15% 110
2025
Q4
$3.65M Buy
67,673
+748
+1% +$36K 0.13% 129
2025
Q3
$3.02M Buy
66,925
+2,026
+3% +$94.6K 0.11% 150
2025
Q2
$3M Buy
64,899
+2,702
+4% +$133K 0.12% 145
2025
Q1
$3.79M Buy
62,197
+3,944
+7% +$230K 0.14% 144
2024
Q4
$3.29M Buy
58,253
+2,769
+5% +$155K 0.12% 152
2024
Q3
$2.87M Buy
55,484
+6,485
+13% +$304K 0.13% 129
2024
Q2
$2.03M Buy
48,999
+1,802
+4% +$80.6K 0.1% 149
2024
Q1
$2.56M Buy
47,197
+2,232
+5% +$114K 0.13% 123
2023
Q4
$2.31M Sell
44,965
-2,836
-6% -$149K 0.13% 122
2023
Q3
$2.77M Sell
47,801
-3,914
-8% -$240K 0.18% 89
2023
Q2
$3.31M Buy
51,715
+1,291
+3% +$86.6K 0.21% 72
2023
Q1
$3.49M Buy
50,424
+4,643
+10% +$327K 0.24% 72
2022
Q4
$3.29M Buy
45,781
+7,600
+20% +$573K 0.26% 74
2022
Q3
$2.71M Buy
38,181
+4,797
+14% +$348K 0.23% 72
2022
Q2
$2.57M Buy
33,384
+4,756
+17% +$362K 0.23% 72
2022
Q1
$2.09M Buy
28,628
+2,035
+8% +$137K 0.16% 91
2021
Q4
$1.66M Buy
26,593
+1,259
+5% +$73.9K 0.13% 108
2021
Q3
$1.5M Buy
25,334
+2,018
+9% +$133K 0.13% 103
2021
Q2
$1.56M Buy
23,316
+139
+0.6% +$9.06K 0.14% 87
2021
Q1
$1.46M Sell
23,177
-995
-4% -$61.9K 0.15% 84
2020
Q4
$1.5M Buy
24,172
+2,556
+12% +$157K 0.16% 76
2020
Q3
$1.3M Buy
21,616
+1,417
+7% +$85.3K 0.16% 70
2020
Q2
$1.19M Buy
20,199
+1,219
+6% +$72.9K 0.17% 71
2020
Q1
$1.06M Buy
18,980
+2,295
+14% +$140K 0.18% 66
2019
Q4
$1.07M Buy
16,685
+2,877
+21% +$165K 0.16% 94
2019
Q3
$700K Buy
13,808
+6,111
+79% +$287K 0.12% 113
2019
Q2
$349K Buy
7,697
+486
+7% +$22.6K 0.06% 174
2019
Q1
$344K Buy
7,211
+596
+9% +$29.7K 0.06% 168
2018
Q4
$344K Buy
6,615
+494
+8% +$26.5K 0.07% 169
2018
Q3
$380K Sell
6,121
-45,686
-88% -$2.71M 0.07% 179
2018
Q2
$2.87M Sell
51,807
-20,049
-28% -$1.08M 0.52% 47
2018
Q1
$4.54M Sell
71,856
-4,159
-5% -$268K 0.8% 40
2017
Q4
$4.66M Sell
76,015
-3,806
-5% -$238K 0.7% 43
2017
Q3
$5.09M Sell
79,821
-7,255
-8% -$424K 0.77% 41
2017
Q2
$4.85M Sell
87,076
-45,566
-34% -$2.48M 0.7% 45
2017
Q1
$7.21M Sell
132,642
-97,337
-42% -$5.34M 0.95% 26
2016
Q4
$13.4M Sell
229,979
-31,531
-12% -$1.72M 1.55% 10
2016
Q3
$14.1M Sell
261,510
-12,593
-5% -$809K 1.53% 12
2016
Q2
$20.2M Sell
274,103
-5,497
-2% -$388K 2.08% 3
2016
Q1
$17.9M Buy
279,600
+35,340
+14% +$2.23M 1.8% 4
2015
Q4
$16.8M Sell
244,260
-20,304
-8% -$1.34M 1.86% 3
2015
Q3
$15.7M Buy
264,564
+68,880
+35% +$4.37M 1.64% 6
2015
Q2
$13M Sell
195,684
-10,857
-5% -$715K 1.28% 12
2015
Q1
$13.3M Buy
206,541
+38,276
+23% +$2.4M 1.24% 11
2014
Q4
$9.93M Sell
168,265
-129,684
-44% -$7.31M 0.86% 26
2014
Q3
$15.2M Buy
297,949
+52,471
+21% +$2.62M 1.1% 11
2014
Q2
$11.9M Buy
245,478
+134,917
+122% +$6.65M 0.81% 27
2014
Q1
$5.74M Sell
110,561
-7,418
-6% -$395K 0.37% 66
2013
Q4
$6.27M Sell
117,979
-9,231
-7% -$470K 0.39% 62
2013
Q3
$5.89M Sell
127,210
-6,803
-5% -$299K 0.38% 63
2013
Q2
$5.99M Buy
+134,013
New +$5.82M 0.38% 60

Other funds holding BMY

Tokio Marine Asset Management's BMY Position: Q1 2026 in Review

Tokio Marine Asset Management increased its Bristol-Myers Squibb (BMY) stake by 4.7% in Q1 2026, buying an estimated $184K and bringing the position to 70,824 shares worth $4.3M. The position accounts for 0.15% of the portfolio, ranked #110.

Tokio Marine Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.2M in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Tokio Marine Asset Management held 70,824 shares of Bristol-Myers Squibb worth $4.3M as of Q1 2026.
  • Tokio Marine Asset Management bought 3,151 Bristol-Myers Squibb shares in Q1 2026, an estimated $184K.
  • Bristol-Myers Squibb made up 0.15% of Tokio Marine Asset Management's portfolio in Q1 2026, its #110 holding.
  • Tokio Marine Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Tokio Marine Asset Management's Bristol-Myers Squibb position peaked at $20.2M in Q2 2016.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tokio Marine Asset Management's 13F filing for Q1 2026, filed 13 May 2026.